GSK, iTeos Therapeutics End Belrestotug Development Program

In This Article:

GSK (GSK) and iTeos Therapeutics (ITOS) said Tuesday they are ending the development program for bel

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.